Subscribe
Momentum studio / Shutterstock.com
1 October 2025NewsAmericasLiz Hockley

Global vaccine patents rise, as data reveals shift in Big Pharma strategy

Research reveals an increase in global filings in 2024/2025, but concerns remain over the future of vaccine development in the US.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Killing the golden goose of US drug innovation (Part I): Follow the money
10 September 2025   In the first of a two-part series, Mercedes Meyer of Banner Witcoff and Brandon Phemester of Novavax explore how legislative, judicial, and executive policies have dramatically altered the risks for drug innovation.
Americas
GSK escalates mRNA COVID-19 vaccine dispute
5 September 2025   The UK pharma giant has opened a new front in its global litigation strategy involving Moderna, Pfizer, and BioNTech.
Americas
$740M deal ends COVID-19 vaccine feud between CureVac and BioNTech
8 August 2025   Payout and licensing deal grants US rights to COVID-19 and flu products | Agreement paves way for BioNTech’s $1.25 billion acquisition of CureVac.


Editor's picks

IP agencies vital to pharma and biotech grind to a halt
Americas
IP agencies vital to pharma and biotech grind to a halt
2 October 2025

Editor's picks

Americas
IP agencies vital to pharma and biotech grind to a halt
2 October 2025
Americas
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
12 September 2025
Americas
Killing the golden goose of US drug innovation (Part I): Follow the money
10 September 2025
Americas
Smart ringleader: Could Ōura’s market dominance be under threat?
5 September 2025
Americas
Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
3 September 2025
Europe
Sandoz blocked by UK court from seeking Xarelto profits
2 September 2025

More features

IP agencies vital to pharma and biotech grind to a halt
USPTO trims workforce amid govt shutdown crisis
How impactful is the new USPTO director’s S101 decision?
Philips wins unprecedented trade secret sanctions against Chinese defendants
Womble Bond Dickinson partners jump to rival firm
EPO ruling clarifies appeal rights, blocking third-party intervention
Biotech sues AstraZeneca and Cellectis over mRNA patents
Trump threatens 100% tariff hike on pharma imports into the US